← Back
Data updated: Jul 17, 2026
PHARMACARE LTD
Pharma Pharmaceuticals
PHARMACARE LTD is a pharmaceutical company with 5 FDA-approved products.
1981
Since
5
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
2 Small Molecules
PHARMACARE LTD's Key Drugs
PHARMACARE LTD's core commercial portfolio centers on LAMIVUDINE AND ZIDOVUDINE — its most strategically important drugs approved in the last 15 years.
PHARMACARE LTD's Recent FDA Approvals
New NDA/BLA approvals for PHARMACARE LTD over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
PHARMACARE LTD's Therapeutic Areas
Disease areas where PHARMACARE LTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
PHARMACARE LTD Pipeline Snapshot
Active clinical trials for PHARMACARE LTD across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • LAMIVUDINE AND ZIDOVUDINE leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 1981-11-30
- Latest
- 2017-03-17
- Applications
- 5
FDA Sponsor Names
PHARMACARE LTDPHARMACARE